Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Cervarix Stories

2012-01-18 20:04:25

Getting the human papillomavirus, or HPV, vaccine provides an important preventative benefit against cervical cancer, said a gynecologic oncologist from Baylor College of Medicine. "Disease prevention and early detection are key in the battle against cancer," said Dr. Celestine Tung, an assistant professor in the department of obstetrics and gynecology in the division of gynecologic oncology at BCM. "With cervical cancer, now we have a way to prevent it with the HPV vaccine." HPV and...

Global Alliance To Purchase Cervical Cancer Vaccines For Underprivileged Girls
2011-11-18 06:05:32

The Global Alliance for Vaccines and Immunization announced on Thursday an initiative to purchase cervical cancer vaccines for up to 2 million women and girls in nine developing nations by 2015. The plan is contingent upon negotiating a final price deal with manufacturers, the group said following a meeting this week in Bangladesh, where GAVI´s board gave the green light to the program. The vaccine would immunize girls and women against the human papillomavirus, or HPV, a sexually...

2011-11-11 06:49:54

(Ivanhoe Newswire) — The HPV (human papillomavirus) vaccine sufficiently protects against the more serious immediate precursor to invasive cervical cancer (ICC), particularly when given to young adolescent girls before they become sexually active, according to this study. In addition the vaccine partially protects against four other cancer-causing HPV types not targeted by the formulations. "Provided that organized vaccination programs achieve high coverage in early adolescents...

2011-10-31 03:00:00

BLUE BELL, Pa., Oct. 31, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that VGX-3100, its investigational SynCon® vaccine for treating cervical dysplasia and cancer caused by human papillomavirus, was highlighted by Fierce Vaccines as one of 10 Promising Therapeutic Vaccines (see VGX-3100 - Cervical cancer). Inovio is currently enrolling patients with CIN...

Government Medical Panel Recommends HPV Vaccine For Boys
2011-10-26 04:54:52

A government medical panel said on Tuesday that the controversial HPV shot given to girls should also be given to boys to help prevent the spread of the sexually transmitted virus. Experts say a key benefit of routinely vaccinating boys could be preventing the spread of the human papilloma virus to others through sex. The Advisory Committee on Immunization Practices made the recommendation on Tuesday. The vaccine has been available to boys for two years but Tuesday's vote was the...

2011-10-05 03:00:00

BLUE BELL, Pa., Oct. 5, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of synthetic vaccines against cancers and infectious diseases, announced today that the company's research to develop a therapeutic synthetic vaccine for cancer won the Edward Jenner Poster Award First Prize at the recent 5th Vaccine and ISV Global Congress. This prestigious prize recognizes the most promising research at the Congress. Inovio's poster, entitled...

2011-09-28 12:42:02

Pediatricians in Appalachia are less likely than doctors in other areas to encourage parents to have their children receive the human papillomavirus (HPV) vaccine, according to a new study. The results are alarming because HPV infection is the most important risk factor for cervical cancer — and studies show that Appalachian women are more likely to get cervical cancer and to die from it than women living elsewhere. "We found that pediatricians in Appalachia were less likely than...

Two Doses Of HPV Vaccine May Offer Enough Protection
2011-09-09 13:18:27

  New government research shows that two doses of the human papillomavirus (HPV) vaccine may offer just as much protection against cervical cancer as the three-dose treatment. According to the study published in the Journal of the National Cancer Institute, the findings come from an analysis of data from the National Cancer Institute's Costa Rica Vaccine Trial.  This trial has 7,466 women enrolled in it. The women were either given the HPV vaccine Cervarix or a Hepatitis A...

2011-07-07 14:56:45

The research will be presented today [Thursday 7 July] at the Annual Scientific Meeting of the Society of Academic Primary Care, hosted this year by the Academic Unit of Primary Health Care, University of Bristol. The HPV vaccination programme, introduced in the UK in 2008, uses HPV vaccine that is effective against the two most common high risk HPV types (16 and 18), and offers 70 per cent protection against cervical cancer. However, vaccinated girls will still need to attend cervical...

2011-06-21 07:27:50

(Ivanhoe Newswire) -- An Australian study is the first to show reduction of high-grade cervical abnormalities (HGAs- the precursors to cervical cancer) in women, following the introduction of human papillomavirus (HPV) vaccination programs. Australia introduced an HPV vaccination program, with the quadrivalent HPV vaccine, for all women aged 12-26 years between 2007 and 2009. In this study, the authors analyzed trends in cervical abnormalities (both high-grade and low-grade [LGAs]) in women...